53 related articles for article (PubMed ID: 19403300)
1. CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer.
Horst D; Kriegl L; Engel J; Jung A; Kirchner T
Eur J Cancer; 2009 Jul; 45(11):2034-40. PubMed ID: 19403300
[TBL] [Abstract][Full Text] [Related]
2. GART Functions as a Novel Methyltransferase in the RUVBL1/β-Catenin Signaling Pathway to Promote Tumor Stemness in Colorectal Cancer.
Tang C; Ke M; Yu X; Sun S; Luo X; Liu X; Zhou Y; Wang Z; Cui X; Gu C; Yang Y
Adv Sci (Weinh); 2023 Sep; 10(25):e2301264. PubMed ID: 37439412
[TBL] [Abstract][Full Text] [Related]
3. Emetine exhibits anticancer activity in breast cancer cells as an antagonist of Wnt/β‑catenin signaling.
Sun Q; Fu Q; Li S; Li J; Liu S; Wang Z; Su Z; Song J; Lu D
Oncol Rep; 2019 Nov; 42(5):1735-1744. PubMed ID: 31436297
[TBL] [Abstract][Full Text] [Related]
4. Effect of Shogaol on the Expression of Intestinal Stem Cell Markers in Experimentally Induced Colitis in BALB/c Mice.
Hassan SMA; Hassan AH
Anal Cell Pathol (Amst); 2019; 2019():5134156. PubMed ID: 30963020
[TBL] [Abstract][Full Text] [Related]
5. CD133 as a regulator of cancer metastasis through the cancer stem cells.
Liou GY
Int J Biochem Cell Biol; 2019 Jan; 106():1-7. PubMed ID: 30399449
[TBL] [Abstract][Full Text] [Related]
6. Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
Yang W; Wang Y; Wang W; Chen Z; Bai G
Med Sci Monit; 2018 May; 24():2864-2872. PubMed ID: 29748529
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.
Testa U; Pelosi E; Castelli G
Med Sci (Basel); 2018 Apr; 6(2):. PubMed ID: 29652830
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic antibodies against cancer stem cells: a promising approach.
Sneha S; Nagare RP; Priya SK; Sidhanth C; Pors K; Ganesan TS
Cancer Immunol Immunother; 2017 Nov; 66(11):1383-1398. PubMed ID: 28840297
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells in human digestive tract malignancies.
Rassouli FB; Matin MM; Saeinasab M
Tumour Biol; 2016 Jan; 37(1):7-21. PubMed ID: 26446457
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide copy number changes and CD133 expression characterized distinct subset of colon polyps: differentiation between incidental polyps and cancer-associated polyps.
Yang CY; Tseng JY; Chen CF; Chou TY; Gao HW; Hua CL; Lin CH; Lin JK; Jiang JK
Int J Colorectal Dis; 2015 Dec; 30(12):1617-26. PubMed ID: 26206347
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of CD133 expression in cancer patients treated with chemoradiotherapy: a meta-analysis.
Zhai JH; Gu WC; Xu XL; Wu J; Hu XJ; Hou KZ
Tumour Biol; 2015 Feb; 36(2):701-9. PubMed ID: 25286754
[TBL] [Abstract][Full Text] [Related]
12. Distinct patterns of ALDH1A1 expression predict metastasis and poor outcome of colorectal carcinoma.
Xu SL; Zeng DZ; Dong WG; Ding YQ; Rao J; Duan JJ; Liu Q; Yang J; Zhan N; Liu Y; Hu QP; Zhang X; Cui YH; Kung HF; Yu SC; Bian XW
Int J Clin Exp Pathol; 2014; 7(6):2976-86. PubMed ID: 25031716
[TBL] [Abstract][Full Text] [Related]
13. Effects of metformin on CD133+ colorectal cancer cells in diabetic patients.
Zhang Y; Guan M; Zheng Z; Zhang Q; Gao F; Xue Y
PLoS One; 2013; 8(11):e81264. PubMed ID: 24278407
[TBL] [Abstract][Full Text] [Related]
14. Colon Cancer Stem Cells: Bench-to-Bedside-New Therapeutical Approaches in Clinical Oncology for Disease Breakdown.
Di Franco S; Mancuso P; Benfante A; Spina M; Iovino F; Dieli F; Stassi G; Todaro M
Cancers (Basel); 2011 Apr; 3(2):1957-74. PubMed ID: 24212791
[TBL] [Abstract][Full Text] [Related]
15. SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition.
Hahn S; Jackstadt R; Siemens H; Hünten S; Hermeking H
EMBO J; 2013 Nov; 32(23):3079-95. PubMed ID: 24185900
[TBL] [Abstract][Full Text] [Related]
16. CD133: a cancer stem cells marker, is used in colorectal cancers.
Ren F; Sheng WQ; Du X
World J Gastroenterol; 2013 May; 19(17):2603-11. PubMed ID: 23674867
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review.
Wen L; Chen XZ; Yang K; Chen ZX; Zhang B; Chen JP; Zhou ZG; Mo XM; Hu JK
PLoS One; 2013; 8(3):e59154. PubMed ID: 23533603
[TBL] [Abstract][Full Text] [Related]
18. CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis.
Chen S; Song X; Chen Z; Li X; Li M; Liu H; Li J
PLoS One; 2013; 8(2):e56380. PubMed ID: 23409180
[TBL] [Abstract][Full Text] [Related]
19. Wnt interaction and extracellular release of prominin-1/CD133 in human malignant melanoma cells.
Rappa G; Mercapide J; Anzanello F; Le TT; Johlfs MG; Fiscus RR; Wilsch-Bräuninger M; Corbeil D; Lorico A
Exp Cell Res; 2013 Apr; 319(6):810-9. PubMed ID: 23318676
[TBL] [Abstract][Full Text] [Related]
20. Wnt/beta-catenin signaling in embryonic stem cell converted tumor cells.
Peng X; Liu T; Wang Y; Yan Q; Jin H; Li L; Qian Q; Wu M
J Transl Med; 2012 Sep; 10():196. PubMed ID: 22995718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
